Skip to main content

Table 1 Baseline clinical and laboratory characteristics of study participants

From: Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study

 

Men

Women

p-value

(n = 178)

(n = 177)

Age (years)

55.9 ± 10.9

60.2 ± 10.2

<0.001

Body mass index (kg/m2)

25.5 ± 3.1

25.2 ± 4.0

0.468

Waist circumference (cm)

90.6 ± 7.0

86.3 ± 10.0

<0.001

Duration of diabetes (years)

7.5 ± 7.3

8.6 ± 7.3

0.143

Systolic blood pressure (mmHg)

128.7 ± 13.5

128.2 ± 14.2

0.726

Diastolic blood pressure (mmHg)

79.3 ± 9.6

78.2 ± 8.9

0.257

Smoking, (never/ex/current)

38/72/68

169/2/6

<0.001

Family history of CHD (%)

12 (6.7)

9 (5.1)

0.654

Menopause

–

139 (78.5)

–

Atrial fibrillation (%)

2 (1.1)

2 (1.1)

0.686

ACE inhibition (%)

61 (34.3)

70 (39.5)

0.323

Antiplatelet medication (%)

51 (28.7)

44 (24.9)

0.472

Statin use (%)

114 (64)

123 (69.5)

0.311

Total cholesterol (mg/dL)

160.9 ± 32.9

169.8 ± 34.3

0.013

Triglycerides (md/dL)

155.3 ± 116.9

138.1 ± 81.3

0.108

HDL-C (mg/dL)

49.3 ± 11.2

54.8 ± 12.8

<0.001

LDL-C (mg/dL)

85.7 ± 28.7

91.3 ± 28.0

0.061

ApoB (mg/dL)

71.3 ± 21.4

71.8 ± 20.3

0.813

ApoA1 (mg/dL)

130.0 ± 27.4

137.8 ± 2.8

0.006

Fasting blood glucose (mg/dL)

137.0 ± 41.9

135.3 ± 39.6

0.694

HbA1c (%)

7.4 ± 1.1

7.5 ± 1.2

0.449

hsCRP (mg/L)a

0.5 ± 0.9

0.5 ± 0.9

0.618

Albumin/creatinine ratioa

12.1 ± 26.7

12.1 ± 28.6

0.239b

  1. Values are mean ± SD; aMedian ± IQR; bThe variable was log transformed before statistical analysis
  2. ACE, angiostensin-converting enzyme; Apo, apolipoprotein; CHD, coronary heart disease; HbA1c, glycated hemoglobin; HDL-C, high density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; IQR, interquartile range; LDL-C, low density lipoprotein cholesterol; SD, standard deviation